Copyright
©The Author(s) 2016.
World J Gastroenterol. Apr 28, 2016; 22(16): 4226-4237
Published online Apr 28, 2016. doi: 10.3748/wjg.v22.i16.4226
Published online Apr 28, 2016. doi: 10.3748/wjg.v22.i16.4226
Table 1 Primers used in this study
| Gene | Primers (5’-3’) | Length (bp) |
| eEF1A2 | GTCAAGGAAGTCAGCGCCTAC | 124 |
| TGAACCACGGCATGTTGGG | ||
| GAPDH | TGACTTCAACAGCGACACCCA | 121 |
| CACCCTGTTGCTGTAGCCAAA |
Table 2 eEF1A2 expression in hepatocellular carcinoma, paired pericarcinomatous and normal liver tissue samples
| eEF1A2 positive tissue/total tissue | Positive rate | |
| HCC | 47/62 | 75.8% |
| Paired pericarcinomatous | 5/62 | 8.1% |
| Normal liver | 0/20 | 0% |
- Citation: Qiu FN, Huang Y, Chen DY, Li F, Wu YA, Wu WB, Huang XL. Eukaryotic elongation factor-1α 2 knockdown inhibits hepatocarcinogenesis by suppressing PI3K/Akt/NF-κB signaling. World J Gastroenterol 2016; 22(16): 4226-4237
- URL: https://www.wjgnet.com/1007-9327/full/v22/i16/4226.htm
- DOI: https://dx.doi.org/10.3748/wjg.v22.i16.4226